All lobbying filings
W Strategies, LLC
W Strategies, LLC filed a Q2 report for Incyte Corporation on July 20, 2026, reporting $60,000 in lobbying income.
Lobbying for Incyte Corporation · ​Biopharmaceutical Company.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Delaware
Lobbyists on this filing
1
-
DARREN WILLCOXPreviously held: Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director
Government bodies contacted
1
Lobbying activity
1
Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.
Bills named in this filing
1